706 related articles for article (PubMed ID: 19347941)
41. Retroviral marking of human bone marrow fibroblasts: in vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo.
Oreffo RO; Virdi AS; Triffitt JT
J Cell Physiol; 2001 Feb; 186(2):201-9. PubMed ID: 11169457
[TBL] [Abstract][Full Text] [Related]
42. The effect of combined application of TGFbeta-1, BMP-2, and COLLOSS E on the development of bone marrow derived osteoblast-like cells in vitro.
van der Zande M; Walboomers XF; Briest A; Springer M; Alava JI; Jansen JA
J Biomed Mater Res A; 2008 Sep; 86(3):788-95. PubMed ID: 18041723
[TBL] [Abstract][Full Text] [Related]
43. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
[TBL] [Abstract][Full Text] [Related]
44. Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells.
Cho SW; Yang JY; Sun HJ; Jung JY; Her SJ; Cho HY; Choi HJ; Kim SW; Kim SY; Shin CS
Bone; 2009 Jun; 44(6):1069-77. PubMed ID: 19254785
[TBL] [Abstract][Full Text] [Related]
45. Differentiation of osteoblast and osteoclast precursors on pure and silicon-substituted synthesized hydroxyapatites.
Lehmann G; Cacciotti I; Palmero P; Montanaro L; Bianco A; Campagnolo L; Camaioni A
Biomed Mater; 2012 Oct; 7(5):055001. PubMed ID: 22781924
[TBL] [Abstract][Full Text] [Related]
46. Cytobiocompatibility of collagen and ePTFE membranes on osteoblast-like cells in vitro.
Friedmann A; Dehnhardt J; Kleber BM; Bernimoulin JP
J Biomed Mater Res A; 2008 Sep; 86(4):935-41. PubMed ID: 18067190
[TBL] [Abstract][Full Text] [Related]
47. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
Huang J; Yuan L; Wang X; Zhang TL; Wang K
Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
[TBL] [Abstract][Full Text] [Related]
48. Contribution of genetically modified mouse models to the elucidation of bone physiology.
Thomas T; Lafage-Proust MH
Rev Rhum Engl Ed; 1999 Dec; 66(12):728-35. PubMed ID: 10649609
[TBL] [Abstract][Full Text] [Related]
49. Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells.
Fukuoka H; Aoyama M; Miyazawa K; Asai K; Goto S
Biochem Biophys Res Commun; 2005 Mar; 328(4):885-94. PubMed ID: 15707961
[TBL] [Abstract][Full Text] [Related]
50. Determining optimal dose of laser therapy for attachment and proliferation of human oral fibroblasts cultured on titanium implant material.
Khadra M; Lyngstadaas SP; Haanaes HR; Mustafa K
J Biomed Mater Res A; 2005 Apr; 73(1):55-62. PubMed ID: 15704112
[TBL] [Abstract][Full Text] [Related]
51. Dioxins interfere with differentiation of osteoblasts and osteoclasts.
Korkalainen M; Kallio E; Olkku A; Nelo K; Ilvesaro J; Tuukkanen J; Mahonen A; Viluksela M
Bone; 2009 Jun; 44(6):1134-42. PubMed ID: 19264158
[TBL] [Abstract][Full Text] [Related]
52. Periostin-like-factor in osteogenesis.
Zhu S; Barbe MF; Liu C; Hadjiargyrou M; Popoff SN; Rani S; Safadi FF; Litvin J
J Cell Physiol; 2009 Mar; 218(3):584-92. PubMed ID: 19006175
[TBL] [Abstract][Full Text] [Related]
53. In vivo effects of low level laser therapy on inducible nitric oxide synthase.
Moriyama Y; Nguyen J; Akens M; Moriyama EH; Lilge L
Lasers Surg Med; 2009 Mar; 41(3):227-31. PubMed ID: 19291752
[TBL] [Abstract][Full Text] [Related]
54. [Impacts of osteoclast-like cells cultured on bone wafer and their sub-cellular structures on osteoblast].
Zhu M; Zhang P; Zhang X; Lu B; Dai CL; Li YM; Qiu MC
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):738-42. PubMed ID: 15949378
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
56. Phosphate decreases osteoclastogenesis in coculture of osteoblast and bone marrow.
Takeyama S; Yoshimura Y; Deyama Y; Sugawara Y; Fukuda H; Matsumoto A
Biochem Biophys Res Commun; 2001 Apr; 282(3):798-802. PubMed ID: 11401534
[TBL] [Abstract][Full Text] [Related]
57. A proteomic study on human osteoblastic cells proliferation and differentiation.
Spreafico A; Frediani B; Capperucci C; Chellini F; Paffetti A; D'Ambrosio C; Bernardini G; Mini R; Collodel G; Scaloni A; Marcolongo R; Santucci A
Proteomics; 2006 Jun; 6(12):3520-32. PubMed ID: 16705754
[TBL] [Abstract][Full Text] [Related]
58. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.
Wang X; Kua HY; Hu Y; Guo K; Zeng Q; Wu Q; Ng HH; Karsenty G; de Crombrugghe B; Yeh J; Li B
J Cell Biol; 2006 Jan; 172(1):115-25. PubMed ID: 16380437
[TBL] [Abstract][Full Text] [Related]
59. The upregulation of osteoblast marker genes in mesenchymal stem cells prove the osteoinductivity of hydroxyapatite/tricalcium phosphate biomaterial.
Sun H; Ye F; Wang J; Shi Y; Tu Z; Bao J; Qin M; Bu H; Li Y
Transplant Proc; 2008 Oct; 40(8):2645-8. PubMed ID: 18929827
[TBL] [Abstract][Full Text] [Related]
60. Cyclic strain induces FosB and initiates osteogenic differentiation of mesenchymal cells.
Haasper C; Jagodzinski M; Drescher M; Meller R; Wehmeier M; Krettek C; Hesse E
Exp Toxicol Pathol; 2008 Apr; 59(6):355-63. PubMed ID: 18222075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
